You are here

RSV

Pfizer revs up to leave GSK in the dust as maternal RSV vax granted FDA breakthrough tag

Fierce Biotech

Wed, 03/2/22 - 12:16 pm

breakthrough status

GSK halts RSV vaccine trials in pregnant women after pause

Pharmaforum

Mon, 02/28/22 - 11:40 am

clinical trials

Moderna begins late-stage study of RSV vaccine using mRNA technology

Yahoo/Reuters

Tue, 02/22/22 - 10:39 am

Moderna Therapeutics

GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal

Fierce Biotech

Fri, 02/18/22 - 10:37 am

clinical trials

J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT

Fierce Pharma

Tue, 02/8/22 - 11:57 pm

drug manufacturing

J&J squares up to Big Pharma rivals with extra RSV vaccine data

Fierce Biotech

Tue, 12/7/21 - 10:56 am

Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers

Fierce Pharma

Wed, 12/1/21 - 11:46 pm

pneumococcal disease

RSVVW 2021 – Pfizer gets maternal

EP Vantage

Mon, 11/1/21 - 11:01 pm

Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine

Motley Fool

Tue, 10/19/21 - 10:45 am

clinical trials

J&J heats up RSV race with new vaccine data

BioPharma Dive

Mon, 10/4/21 - 10:58 pm

clinical trials

Could This Be Pfizer's Next Blockbuster Vaccine?

Motley Fool

Fri, 09/10/21 - 11:00 am

clinical trials

GSK, J&J and Pfizer vie for $10B RSV vaccine market, with Bavarian Nordic and Moderna hot on their trail

Endpoints

Tue, 09/7/21 - 12:03 pm

Bavarian Nordic

Moderna Therapeutics

Pfizer, marking fast research pace, starts key trial of RSV vaccine

BioPharma Dive

Thu, 09/2/21 - 09:59 pm

clinical trials

Bavarian Nordic gets a vaccine booster

EP Vantage

Thu, 09/2/21 - 09:18 am

Bavarian Nordic

Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too

MedCity News

Sun, 08/1/21 - 11:53 pm

Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work

Fierce Biotech

Fri, 07/30/21 - 11:08 am

clinical trials

Moderna plans triple vaccine targeting flu, COVID and RSV

Pharmaforum

Thu, 07/8/21 - 10:58 am

Moderna Therapeutics

Sanofi, AstraZeneca mark big leap toward filing of RSV drug in 2022, with safety data in hand to challenge Synagis

Endpoints

Mon, 06/28/21 - 10:58 am

clinical trials

AstraZeneca and Sanofi Announce Big Breakthrough With RSV Vaccine

BioSpace

Mon, 04/26/21 - 10:41 am

clinical trials

Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot

Fierce Biotech

Wed, 04/14/21 - 09:38 am

Moderna Therapeutics

Pages